STOCKHOLM, May 28, 2024 /PRNewswire/ The Board of Directors of Calliditas Therapeutics AB (publ) unanimously recommends that the shareholders and holders of American Depositary Shares ("ADS")
Offer price of HK$34.00 in cash per share is final and represents approximately 60.83% premium to undisturbed 60-trading day average closing price of HK$21.14 per share.€1.7 billion take-private.
HONG KONG and LUXEMBOURG, April 29, 2024 /PRNewswire/ The Board of Directors (the "Board") of L'Occitane International S.A. (the "Company"), (Stock Code:
Securities Industry Council ("SIC" or the "Council") Public Statement on Allied Technologies Limited mas.gov.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mas.gov.sg Daily Mail and Mail on Sunday newspapers.